Implications of reverse cholesterol transport: recent studies.

Area of Science:

• Cardiovascular Disease Research
• Lipid Metabolism
• Molecular Biology

Background:

• Epidemiological studies show a strong link between high-density lipoproteins (HDL) and atherosclerotic coronary vascular disease (ASCVD).
• The reverse cholesterol transport (RCT) process is hypothesized to mediate this relationship, suggesting that increasing HDL should reduce ASCVD risk.
• Recent advancements have improved understanding of HDL metabolism, leading to a proposed RCT process superimposed on known pathways.

Purpose of the Study:

• To evaluate the validity of the current reverse cholesterol transport (RCT) hypothesis.
• To assess the association between HDL cholesterol (HDLC) levels and ASCVD risk.
• To examine the impact of interventions aimed at raising HDLC or mimicking HDL on ASCVD.

Main Methods:

• Literature review of genetic defect studies (ABCA1, LCAT, SR-B1).
• Analysis of HDL cholesterol-raising clinical trials (niacin, cholesteryl ester transfer protein inhibitors).
• Examination of Mendelian randomization studies and treatments with HDL-mimicking molecules.

Main Results:

• Genetic studies showed HDLC variations but limited association with ASCVD.
• Mendelian randomization studies found no significant link between HDLC and ASCVD.
• Clinical trials and HDL-mimicking treatments that raised HDLC did not significantly reduce ASCVD risk.

Conclusions:

• Recent evidence does not support the proposed RCT hypothesis as currently formulated.
• The association between HDLC and ASCVD requires re-evaluation.
• Substantial revision of the RCT hypothesis is necessary based on current scientific findings.